As of October 2023, among the 69 heterosexual patients coinfected with HIV-1/Hepatitis B, 39 (56.5%) patients were in active care and follow-up and on ART with a median CD4+ count of 434 cells/mm3 (p = 0.73) and a median HIV-1 viral load of <40 copies/mL (p = 0.10), there were 15 (21.7%) deaths (p = 0.34) and 15 (21.7%) were lost to follow-up (p = 0.54). Here, CD4 is linked to hepatitis B virus infection.